Home › Calculator › SRZN Dividend Calculator 2026
SRZN Dividend Calculator 2026
No dividendHealthcareSurrozen, Inc. · NASDAQ
Price: $25.48 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
SRZN is not a dividend-focused stock
SRZN pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
SRZN Dividend Yield
Surrozen, Inc. (SRZN) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SRZN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Surrozen, Inc. (SRZN) — Dividend Analysis 2026
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs’ endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
SRZN Dividend & DRIP — Frequently Asked Questions
Does SRZN pay a dividend?
No. Surrozen, Inc. (SRZN) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of SRZN?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does SRZN have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. SRZN has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to SRZN
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SRZN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SRZN position with:
🌍 SRZN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SRZN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SRZN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SRZN Dividend Payment Schedule
SRZN pays quarterly — 4 times per year. Ex-div: —.
📊 SRZN vs Healthcare Benchmarks
How SRZN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SRZN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SRZN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| X-InTheMoney | 2026-10-20 | 548,653 | $11.60 | $6.36M | ||
| X-InTheMoney | 2026-10-20 | 485,830 | $11.60 | $5.64M | ||
| X-InTheMoney | 2026-10-20 | 517,241 | $11.60 | $6.00M | ||
| X-InTheMoney | 2026-10-20 | 274,327 | $11.54 | $3.17M | ||
| X-InTheMoney | 2026-10-20 | 258,620 | $11.54 | $2.98M | ||
| X-InTheMoney | 2026-10-20 | 242,915 | $11.54 | $2.80M | ||
| X-InTheMoney | 2026-10-20 | 775,861 | $11.60 | $9.00M | ||
| X-InTheMoney | 2026-10-20 | 548,653 | $11.60 | $6.36M | ||
| X-InTheMoney | 2026-10-20 | 485,830 | $11.60 | $5.64M | ||
| X-InTheMoney | 2026-10-20 | 517,241 | $11.60 | $6.00M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare SRZN with peers: SRZN vs AGEN · SRZN vs ATOS · SRZN vs CGTX
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where SRZN earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SRZN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Surrozen, Inc. (SRZN) is currently trading at $25.48, 33% below its 52-week high. It does not currently pay a regular dividend.
Does SRZN Pay a Dividend? Surrozen, Inc. Dividend Status
Surrozen, Inc. (SRZN) is a healthcare stock trading at $25.48. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SRZN News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your SRZN DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.